Siga Technologies (SIGA) Shares Outstanding (Weighted Average) (2010 - 2025)
Siga Technologies (SIGA) reported Shares Outstanding (Weighted Average) of $71.6 million for Q4 2025, up 0.5% on a YoY basis from $71.3 million in Q4 2024, and little changed quarter-over-quarter from $71.6 million in Q3 2025.
Siga Technologies (SIGA) Shares Outstanding (Weighted Average) (2010 - 2025) Analysis & Trends
Siga Technologies has reported Shares Outstanding (Weighted Average) for 16 years, with the latest figure at $71.6 million in Q4 2025.
- For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) rose 0.5% year-over-year to $71.6 million; the trailing twelve-month figure through Dec 2025 stood at $71.6 million (up 0.5% YoY), and the FY2025 full-year result was $71.6 million, up 0.5% from the prior year.
- Shares Outstanding (Weighted Average) for Q4 2025 stood at $71.6 million, roughly flat from $71.6 million in the prior quarter.
- The five-year high for Shares Outstanding (Weighted Average) was $76.8 million in Q1 2021, with the low at $71.1 million in Q3 2023.
- Historically, Shares Outstanding (Weighted Average) has averaged $72.6 million across 5 years, with a median of $71.6 million in 2023.
- Annual changes were most pronounced in 2021 — Shares Outstanding (Weighted Average) dropped 6.16% — and 2025, when it rose 0.58%.
- Siga Technologies' Shares Outstanding (Weighted Average) stood at $75.3 million in 2021, then retreated by 3.18% to $72.9 million in 2022, then declined by 2.15% to $71.4 million in 2023, then slipped by 0.15% to $71.3 million in 2024, then gained by 0.5% to $71.6 million in 2025.
- The last three Shares Outstanding (Weighted Average) figures came in at $71.6 million (Q4 2025), $71.6 million (Q3 2025), and $71.4 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 1.16 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 422.10 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 43.50 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 5.02 Bn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 100.50 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 497.70 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 166.20 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 64.74 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 228.36 Mn |
| 10 | Siga Technologies | 310.79 Mn | 155.83 Mn | - | 71.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 71.61 Mn |
| Sep 30, 2025 | 71.60 Mn |
| Jun 30, 2025 | 71.45 Mn |
| Mar 31, 2025 | 71.43 Mn |
| Dec 31, 2024 | 71.25 Mn |
| Sep 30, 2024 | 71.19 Mn |
| Jun 30, 2024 | 71.12 Mn |
| Mar 31, 2024 | 71.09 Mn |
| Dec 31, 2023 | 71.36 Mn |
| Sep 30, 2023 | 71.08 Mn |
| Jun 30, 2023 | 71.64 Mn |
| Mar 31, 2023 | 72.20 Mn |
| Dec 31, 2022 | 72.93 Mn |
| Sep 30, 2022 | 73.02 Mn |
| Jun 30, 2022 | 72.68 Mn |
| Mar 31, 2022 | 73.07 Mn |
| Dec 31, 2021 | 75.32 Mn |
| Sep 30, 2021 | 75.82 Mn |
| Jun 30, 2021 | 75.81 Mn |
| Mar 31, 2021 | 76.76 Mn |